Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study - Concepedia

Concepedia

Publication | Open Access

Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study

DOI Full Paper Access

20

Citations

11

References

2021

Year

Lisa A. Beck, Diamant Thaçi, Mette Deleuran, Marjolein de Bruin‐Weller, Zhen Chen, Faisal A. Khokhar, Meng Zhang, Zafer E. Ozturk, Brad Shumel

Journal of Dermatological Treatment

Abstract

NCT01949311.

References

	Year	Citations

Page 1